Mythic Therapeutics
WALTHAM, MA · Founded 2018 · CIK 0001819730 · Biotech · Defunct
HALO antibody-drug conjugate (ADC) platform with tumor microenvironment-activated payloads for solid tumors
mythictx.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $53M
- 3 Form D · Dec 2024
- 21 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 40
- 4 granted · 36 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓202020212022202320242025
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised· 1 of 2 same day | Form D · SEC | $18,849,989 | |
| Private capital raised· 2 of 2 same day | Form D · SEC | $4,749,262 | |
| Private capital raised | Form D · SEC | $29,868,794 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2335 | TERAIMMUNE, INC. | — | $3.0M |
| 2336 | Decibel Therapeutics | — | $63M |
| 2337 | 3P BIOTECHNOLOGIES, INC. | — | — |
| 2338 | Mythic Therapeutics | — | $53M |
| 2339 | DEEPSEQAI LLC | — | — |
| 2340 | Tallac Therapeutics, Inc. | — | $21M |
| 2341 | AION Healthspan, Inc. | — | $2.9M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- George EliadesDirector · Executive Officer
- Brian FiskeDirector · Executive Officer · Promoter
- Jason HansonDirector
- Peter HechtDirector
- Josh KopelmanDirector
- Alex NicholsDirector · Executive Officer · Promoter
- Sandra PooleExecutive Officer
- Bryan RobertsDirector
Patents
- Antigen-binding Protein Constructs And Uses Thereofgranted
- ANTI-DLL3 Antibodies And Methods Of Usegranted
- pH-dependent Antigen-Binding Constructs Specific to FOLR 1granted
- LRRC-15-BINDING Protein Constructs And Uses Thereofapplication
- Anti-cMet Antibody-Drug Conjugates and Uses Thereofgranted
- ANTI-cMET ANTIBODY DRUG CONJUGATES AND THERAPEUTIC USES THEREOFapplication
- Antigen-binding Protein Constructs And Antibodies And Uses Thereofapplication
- Anti-met Antibodies And Uses Thereofapplication
- Antigen-binding Protein Constructs And Uses Thereofapplication
- Antigen-binding Protein Constructs And Uses Thereofapplication
- Antigen-binding Protein Constructs And Uses Thereofapplication
- Antigen-binding Protein Constructs And Uses Thereofapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.